Navigation Links
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
Date:11/6/2012

n patients whose tumours express Fn14 might prevent cancer cells from growing and proliferating."

Fn14 is over-expressed in at least 30% of several solid tumours, including pancreatic cancer, breast cancer, non-small cell lung cancer and malignant melanoma.

From July 2011, Dr Lassen and his colleagues recruited 38 patients with treatment-refractory solid tumours to the phase I trial. All patients had tumours expressing the Fn14 receptor. They received an intravenous dose of the drug either once weekly or once every three weeks, with a dose range of 200 to 3600 mg.

Dr Lassen said: "Several of the patients continue to receive study treatments, and encouraging signs of clinical benefit have already been observed. A patient with heavily pre-treated, metastatic melanoma with no mutation in the BRAF gene has shown evidence of tumour regression when scanned using computerised tomography (CT) and remains on study after more than 30 weeks of treatment. Four other patients have had partial metabolic responses confirmed by positron emission tomography (PET) scans.

"Prolonged stable disease has been seen in several patients. Overall, 11 of the 38 patients (29%) have received more than 12 weeks of study treatment, with several receiving 18 or more weeks of RG7212 therapy, including those with refractory NSCLC, melanoma, mesothelioma, breast cancer, renal cell carcinoma, and biliary tract cancer.

"We found that RG7212 has an excellent safety profile across a broad dose range on each schedule. We saw no dose-limiting toxicities and no patient discontinued study treatments for treatment-related adverse side-effects. The phase I data show that RG7212 is quite safe for multi-cycle administration in patients with advanced cancer. Results from tests of blood and tumour samples suggest that it would be feasible to administer the drug over a prolonged period of time.

"There are encouraging pharmacodynamic data (effects of the drug on
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
2. NIH scientists map first steps in flu antibody development
3. Scientists Pinpoint Antibody That May Be Specific to MS Patients
4. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
5. Molecule found that inhibits recovery from stroke
6. Bloodstream scavenger inhibits clotting without increased bleeding
7. Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading
8. IU researchers report first effective treatment of tumors arising from common genetic disease NF1
9. Quality of Life After Cancer May Depend on Tumor Type
10. Socioeconomic disadvantage linked to breast cancer tumor disparity
11. Minorities most likely to have aggressive tumors, less likely to get radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 01, 2014 According to a new ... Pyrometer Market by product Types, Applications (Automotive, Petrochemical, Consumer ... America, Europe, APAC, RoW) - Analysis & Forecast to ... is estimated to grow to $1.42 Billion by 2020 ... market is estimated to grow to $238.17 Million by ...
(Date:8/1/2014)... 2014 Recently, Agebc.com, a renowned wedding dress ... prom dresses . As a matter of fact, all items ... Aside from that, all of them are offered at promotional ... huge selection of graceful products for clients who want to ... not last for a long period of time. Ladies who ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 The North America ... market in North America, with analysis and forecast of revenue. ... grow from around $5,021.9 million in 2012 to $6,243 million ... period. , Browse through the TOC of the North America ... in-depth analysis provided. This also provides a glimpse of the ...
(Date:8/1/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... J. Jill Suitor, PhD, of Purdue University as ... to Gerontology Award. , This distinguished honor is ... have helped bring about a new synthesis and ... designs addressing a significant problem in the literature. ...
(Date:8/1/2014)... the nation,s largest interdisciplinary organization devoted to the ... MA, MD, FRCPI, AGSF, FRCP(Glasg), FRCP, FRCP(Edin), of Tallaght ... recipient of the Joseph T. Freeman Award. , This ... is awarded to a prominent physician in the field ... who is a member of the Society,s Health Sciences ...
Breaking Medicine News(10 mins):Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 2Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 3Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 4Health News:Cheap Prom Dresses At The Renowned Dresses Manufacturer and Retailer Agebc.com 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Suitor to receive GSA's 2014 Distinguished Career Contribution to Gerontology Award 2Health News:O'Neill to receive GSA's 2014 Joseph T. Freeman Award 2
... that could stop the growth of glioblastoma, a deadly form ... journal Cell , a Cell Press publication, a new ... allows them to grow and seed tumors. Importantly, normal stem ... that same dependency. "When thinking about therapeutics [targeting cancer ...
... entomology, Bradley Mullens , a professor of entomology at ... of the prestigious Entomological Society of America (ESA), ... scientific needs of entomologists and people in related disciplines. ... were elected to this honor. They will be recognized at ...
... , WEDNESDAY, July 6 (HealthDay News) -- For the millions ... to alleviate the condition has yet to be identified, a ... therapy (SMT) to other treatments such as medication, exercise or ... to be no better or worse than other options at ...
... a suitable donor for leukemia and lymphoma patients who ... that results of two clinical trials show transplant results ... comparable to fully matched tissue, thanks in large part ... post-transplant chemotherapy. The finding means that nearly all ...
... acquisition of speech, but 2 of every 1000 children ... treatment can help these children learn to speak. In ... Martin Ptok of Hannover Medical School explores whether screening ... early diagnosis, and the potential risks of newborn hearing ...
... , THURSDAY, July 7 (HealthDay News) -- Expanding ... use, improves health and well-being and reduces the ... health coverage, according to new research. "This ... and use of care for low-income adults relative ...
Cached Medicine News:Health News:To combat deadly brain cancer, target the stem cells 2Health News:UC Riverside faculty member elected fellow of Entomological Society of America 2Health News:Study Questions Chiropractic's Impact on Back Pain 2Health News:Study Questions Chiropractic's Impact on Back Pain 3Health News:Half-matched transplants widen pool of donors for leukemia and lymphoma 2Health News:Half-matched transplants widen pool of donors for leukemia and lymphoma 3Health News:Medicaid Coverage 'Substantially' Improves Access to Care: Study 2
(Date:8/1/2014)... 1, 2014 Research and Markets ... "Global Medical Biosensors Market 2014-2018" report to ... Medical biosensors are used to ... detectors. These biosensors monitor health status, disease betterment, ... methods. They are cost-effective and user-friendly devices. Also, ...
(Date:8/1/2014)... PALO ALTO, Calif. , Aug. 1, ... (CFRI) today announced a partnership to expand awareness of ... through the CFChef Shares program. CFChef Shares will run ... of AbbVie,s CFChef program – an online resource for ... maintain a healthy diet by submitting recipes to the ...
(Date:8/1/2014)... DALLAS , August 1, 2014 ... Care Market by Type (Traditional Wound Closure, Anti infective), ... Active (Artificial Skin & Skin Substitutes), Pressure Relief ... by MarketsandMarkets, the global Wound Care Market is expected ... Billion in 2014, growing at a CAGR of ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: